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Abstract
Purpose Side-effects of adjuvant endocrine therapy (AET) are common in breast cancer survivors, and can affect adherence 
to treatment. We synthesised the evidence for strategies to self-manage these side-effects.
Methods We searched for systematic reviews and clinical guidelines on self-management strategies for AET side-effects 
(arthralgia, fatigue, hot flashes, gastrointestinal discomfort, nausea, vulvovaginal symptoms, and sleep disturbance). We 
searched oncology organisation’s websites and eight databases (Inception-November 2020). Screening, data extraction and 
quality assessment were completed independently in duplicate. PROSPERO: 2019CRD4201914001.
Results We identified 33 systematic reviews and 18 clinical guidelines. 21% of reviews were high quality, and the average 
quality score for guidelines was 44%. Evidence for most strategies was absent or weak. There was consensus from a low-
quality review and multiple guidelines to recommend moisturisers, gels and lubricants for vulvovaginal symptoms. Evidence 
was weak for physical activity for self-managing most symptoms, although two high-quality reviews indicated yoga and 
aerobic exercise could reduce fatigue. Primary research was often biased by weak and underpowered study designs. Eleven 
reviews did not report information on adverse events.
Conclusions Most self-management strategies for breast cancer survivors experiencing side-effects from AET lack evidence. 
Primary research is needed using high-quality well-powered designs focusing on implementable strategies.
Implications for Cancer Survivors Patients and clinicians should be aware that although the risk of harm is low for these self-
management strategies, the likelihood of benefit is often unclear. Women should consider moisturisers, gels or lubricants for 
self-managing vulvovaginal symptoms, and yoga or aerobic exercise for alleviating fatigue.
Keywords Breast cancer · Adjuvant endocrine therapy · Complementary therapy · Self-management · Systematic review · 
Side-effects
Introduction
Breast cancer is the most common cancer in women world-
wide, and the leading cause of cancer death [1]. Most 
tumours are oestrogen-receptor positive (ER +), which can 
be treated in the adjuvant setting with endocrine therapies. 
These include tamoxifen and Aromatase Inhibitors (AIs), 
such as letrozole, anastrozole, and exemestane. Com-
mon side-effects reported by tamoxifen users include hot 
flashes, fatigue and vulvovaginal symptoms, while arthral-
gia is commonly reported in women using AIs [2–6]. Most 
women experiencing these symptoms want more support 
to manage them [6]. Experiencing these symptoms can 
reduce quality of life [2, 7–11], and is likely to contribute 
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to the estimated three-quarters of women who struggle 
to adhere to and persist with adjuvant endocrine therapy 
(AET) [12]. Patients and oncologists perceive side-effects 
to be a major deterrent to AET adherence [13, 14].
Women with breast cancer who do not adhere to AET 
have an increased risk of all-cause and cancer-specific 
mortality [15–19] and recurrence [16, 20, 21]. It is there-
fore important to provide evidence-based support to 
women experiencing side-effects from AET. Women often 
self-manage these side-effects [6], but use a wide range 
of strategies which may not be evidence-based. There is 
a large volume of scientific research and clinical guide-
lines available on this topic. Therefore, an overall exami-
nation of this body of information is needed to identify 
consistencies and discrepancies in recommendations, and 
to provide patients and healthcare professionals with clear 
evidence-based advice for managing these symptoms [22]. 
We undertook a systematic review of systematic reviews 
and clinical guidelines (also called an umbrella review) 
to synthesise evidence for self-management strategies for 
side effects among women using AET. This approach pro-
vides a method for summarising a broad topic of related 
issues, thereby providing a single source of information 
for patients, healthcare professionals and research scien-
tists. The inclusion of clinical guidelines within the review 
will enable us to observe the extent to which evidence is 
being translated into clinical practice recommendations, 
to identify self-management strategies recommended by 
clinical guidelines that are not supported by evidence, and 
to assess the quality of guidelines informing clinical care.
Methods
We were interested in literature related to individual-level 
non-pharmacological or lifestyle treatments or manage-
ment strategies that could be accessed without seeking 
a prescription or referral from a healthcare professional. 
These interventions could be compared against no inter-
vention, usual care or other strategies or treatments, 
including those administered by a healthcare professional. 
We were interested in systematic reviews and clinical 
guidelines reporting outcome measures assessing AET 
side-effects. We created a list of all side-effects associ-
ated with tamoxifen, letrozole, anastrozole, and exemes-
tane and presented them to two primary care physicians 
(RF and RN). Consensus was reached that the following 
could be safely managed without initially seeking sup-
port from a healthcare professional: arthralgia (including 
joint pain and joint disorders), gastrointestinal discomfort, 
fatigue, hot flashes, nausea, vulvovaginal symptoms, and 
sleep disturbance.
The review was prospectively pre-registered (PROSPERO 
2019 CRD4201914001). We adhered to the PRISMA 2020 
checklist throughout [23].
Search strategy
In March 2019, we searched for systematic reviews examin-
ing the self-management strategies of common side effects 
experienced by breast cancer patients being treated with 
AETs. We updated the searches in November 2020. The 
following databases were searched from inception to pre-
sent; CINAHL, Cochrane, Embase, Medline, and Web of 
Science (Appendix). The database searches were developed 
for three search concepts: breast cancer; tamoxifen or Aro-
matase Inhibitors and generic and specific side effects. Data-
base subject headings and free text words were identified 
by the Information Specialist (NK) and project team mem-
bers (SS, LH). The search was peer-reviewed by another 
Information Specialist using the PRESS checklist [24]. To 
identify relevant clinical guidelines, we searched for AETs 
and the named side-effects in the following websites in July 
2019 and November 2020: American Society for Clinical 
Oncology (ASCO), European Society of Medical Oncol-
ogy (ESMO), NIH National Cancer Institute (NCI), National 
Comprehensive Cancer Network (NCCN), Scottish Intercol-
legiate Guidelines Network (SIGN), and National Institute 
for Health and Care Excellence (NICE) Evidence. We also 
searched the guidelines databases; Turning Research Into 
Practice (TRIP), International Guidelines Library (GIN), and 
National Health and Medical Research Council (NHMRC) 
Australian Clinical Practice Guidelines. The results were 
stored and deduplicated using Endnote X9 software. Further 
relevant studies were sought by backward citation searching 
of the included studies.
Study selection
Screening was conducted in two stages using Covidence 
software. Two authors (SS, LH, or ER) independently 
screened the titles and abstracts for eligibility and conducted 
the full text screen. Disagreements were resolved through 
discussion with a third author (CG). We included systematic 
reviews and meta-analyses and guidelines from societies, 
government agencies and charities with the following crite-
ria; women with breast cancer using AET (e.g. tamoxifen, 
aromatase inhibitors, anastrozole, letrozole or exemestane). 
The interventions were individual-level, non-pharmacologi-
cal or lifestyle treatments or management strategies available 
without a prescription or referral from healthcare profes-
sionals. They could be compared against usual care, other 
self-management strategies, or treatments administered by a 
healthcare professional. We excluded narrative reviews and 
studies reporting primary data, reviews focussed mainly on 
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cancers other than breast cancer, symptoms not associated 
with AET, switching treatments, the neoadjuvant setting or 
side-effects that require clinical management.
Data collection
Data extraction was conducted in Microsoft Excel in dupli-
cate (SS, LH), with a third author (KL) arbitrating any disa-
greements. The data extraction form was piloted before full 
data extraction took place. Key study variables extracted 
for the systematic reviews are shown in Table 1. We also 
extracted information on study designs eligible, approach to 
synthesis, self-management strategies reported, sample size 
and effect sizes in meta-analysis, key findings and limita-
tions. Key study variables extracted for the clinical guide-
lines are shown in Table 2.
Evidence synthesis
Studies and guidelines were summarised in tables, and 
were classified into 3 categories: ‘X’ = Overall, no evidence 
or low-quality evidence in support of the intervention or 
high-quality evidence against the intervention; ‘?’ = mixed 
evidence with some evidence in favour of the intervention 
and some negative or null evidence against the intervention 
or no evidence provided for recommendation; ‘✔’ = Overall, 
more evidence or higher quality evidence in favour of the 
intervention than against it. We also undertook a narrative 
synthesis of the data. We first synthesized the data from the 
systematic reviews and guidelines independently, and then 
combined them to identify consistencies and discrepancies 
in terms of the strategies evaluated, and the conclusions 
drawn. There was high heterogeneity across the reviews and 
guidelines with regard to quality, strategies and side-effects 
included, and therefore no further quantitative synthesis was 
performed. We grouped reviews and guidelines thematically 
by side-effects, and self-management strategies reported. 
Higher quality reviews and guidelines were prioritised in 
the narrative synthesis when multiple data sources were 
available. However, lower quality reviews and guidelines were 
included to increase the sensitivity for identifying potential 
self-management strategies, and to enable us to provide 
recommendations for how progress can be made in this field.
The quality of systematic reviews was independently 
assessed using the AMSTAR-2 checklist by two authors (SS 
and LH), with disagreements resolved by a third author (KL). 
Seven domains assessed to produce a single quality score of 
critically low, low, moderate and high [25]. These include 
protocol registration, adequacy of the search, exclusion 
criteria justification, risk of bias from individual studies, 
appropriateness of meta-analytical methods, consideration 
of risk of bias when interpreting results, and assessment and 
impact of publication bias. Three authors (KL, SS and AB) 
independently used the AGREE-2 checklist to assess the 
quality of the clinical guidelines across six domains [26]. 
These include scope and purpose, stakeholder involvement, 
rigour of development, clarity of presentation, applicability, 
editorial independence. An average of their scores was 
computed. Guidelines with scores > 50% were considered 
‘higher quality’.
Changes from pre‑registration
We did not extract data related to medication adherence, 
or broader outcomes related to side-effects such as quality 
of life or physical function. We also assessed the quality of 
the clinical guidelines using the AGREE-2 checklist. Some 
clinical guidelines also had separate document intended for 
patients rather than healthcare professionals. Where these 




The final database searches for systematic reviews retrieved 
906 records. After duplicates were removed 580 titles and 
abstracts were screened and 70 full texts were reviewed. 
Thirty-three systematic reviews were eligible, including 10 
identified via backward citation searching (Supplementary 
Figure S1). We identified 1426 clinical guidelines, and after 
deduplication 953 titles were screened, and 122 full guide-
lines were reviewed. Eighteen clinical guidelines were eligi-
ble, including one guideline identified via backwards citation 
searching (Supplementary Figure S2).
The quality of the systematic reviews was mixed. Four 
systematic reviews had critically low quality [27–30], nine 
were low quality [31–39], 13 moderate quality [40–52], and 
seven high quality [53–59] (Table 1). There were consistent 
weaknesses within the reviews. The quality assessment 
ratings for each systematic review are available in Appendix 
Table  S1 and S2. No reviews reported the source of 
study funding, and pre-registrations and explanations for 
deviating from protocols was uncommon (six adherent 
[50, 54, 56–59], one partially adherent [40]). Six reviews 
failed to disclose author conflicts of interest or how they 
managed existing conflicts [29, 30, 32, 33, 46, 48]. The 
mean overall quality score of the clinical guidelines was 
44%, ranging from 24 [60] to 71 [61] (Table 3). Guidelines 
scored particularly strongly on the ‘scope and purpose’ 
(mean = 72%) and ‘clarity of presentation’ (mean = 71%) 
domains, but ‘applicability’ (mean = 11%) and ‘editorial 
independence’ (24%) was lower.
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Fifteen systematic reviews used a narrative synthesis [27, 
29–31, 35–39, 42, 43, 45, 47, 53, 54], and 18 included at 
least one meta-analysis [28, 32–34, 40, 41, 44, 46, 48–52, 
55–59]. On average, the articles included 7.9 (range of 2–26) 
relevant primary studies. The most common assessment of 
methodological quality was the Cochrane Risk of Bias Tool 
(n = 18) [31, 38, 40, 42–45, 47, 49–51, 53–59]. Reporting 
of adverse events resulting from the strategies evaluated was 
generally poor, and not reported by 11 systematic reviews 
[29, 34–37, 39, 47, 48, 52, 55, 58]. Reports from the remain-
ing reviews indicated adverse events were minor (Table 1).
The majority of the guidelines originated in the USA 
(n = 10) [61–70], with the remainder originating in Aus-
tralia (n = 3) [71–73], the UK (n = 3) [60, 74, 75], Canada 
(n = 1) [76], and Europe (n = 1) [77]. Sixteen guidelines 
were intended for healthcare professionals [60–70, 73–77], 
one for patients only [72], and one for both healthcare pro-
fessionals and patients [71]. Fourteen guidelines explicitly 
reported their methodology for identifying their recommen-
dations [61–71, 74, 76, 77]. When describing self-manage-
ment strategies, seven referred to systematic reviews [60, 62, 
65, 67, 68, 75, 76], 12 included randomised trials [60–67, 
69, 71, 75, 76]; three referred to observational data [61, 65, 
66] and two referred to expert opinion [66, 74]. One did not 
report the basis for the recommendation [72]. Ten provided 
a grading system for the strength of the evidence [61–67, 
69, 71, 77].
Arthralgia
Fourteen systematic reviews [27, 28, 31–33, 39–41, 44, 
47–50, 59] and four clinical guidelines [61, 72, 73, 75] 
reported on five self-management strategies for arthralgia. 
One review was rated as high quality [59]. The guidelines 
scored between 32% [72] and 71% [61] in terms of quality. 
An overall summary of findings from the systematic reviews 
and clinical guidelines is shown in Table 4.4.
Acupuncture
Eleven systematic reviews reported on the use of acupunc-
ture for arthralgia [27, 28, 31–33, 39–41, 44, 47, 48]. There 
were no high-quality reviews. Two moderate quality reviews 
[40, 44], one higher quality clinical guideline [61], and one 
lower quality clinical guideline [75] reported evidence sup-
porting the use of acupuncture for arthralgia, but multi-
ple limitations were noted with studies in this area. These 
included a tendency to report within group differences rather 
than between group differences in trial outcomes, short-term 
follow-up and small sample sizes. A third moderate quality 
review and meta-analysis reported the effect of acupuncture 
on arthralgia was not statistically significant in the five trials 
synthesised.
Physical activity
Eight systematic reviews [28, 33, 39, 47–50, 59] and three 
clinical guidelines [61, 72, 73] reported on physical activity 
as a self-management strategy for arthralgia. One systematic 
review [59] and one clinical guideline [61] were rated as high 
quality. Activities reported included yoga [28, 33, 39, 47, 48, 
72], walking [28, 33, 47–49, 59, 72], Nordic walking [33, 48], 
aerobic and resistance training [28, 33, 39, 47–50, 59, 61, 73], 
aquatic exercise [33, 49, 72], and Tai-Chi [33]. A high-qual-
ity review reported no clear evidence of benefit for exercise 
therapy to address arthralgia [59]. This finding was supported 
by most evidence from the lower quality reviews, particularly 
those focussed on low intensity interventions such as yoga and 
Tai-Chi. One large randomised controlled trial was included in 
all systematic reviews [28, 33, 39, 47–50, 59] and one of the 
clinical guidelines [72], and reported supervised aerobic and 
resistance training could improve arthralgia in this population.
Supplements
Two moderate quality systematic reviews [47, 48], two low-
quality systematic reviews [33, 39] and a critically low-
quality systematic review [28] reported on the use of sup-
plements to address arthralgia. Two lower quality clinical 
guidelines also reported on the use of supplements for this 
indication [75], of which one was patient-facing and did not 
refer to any evidence [72]. Supplements reported included 
vitamin D [28, 33], vitamin E [33], omega-3 fatty acids [33, 
39, 47, 75], Glucosmine sulfate [33, 47, 75], chondroitin-
sulfate [47], kampo medicine [47], sodium selenite plant 
enzmes [47], lens culinaris lectin [47], Blue Citrus Herbal 
[33], high dose vitamin B2 [75], and unspecified vitamins 
[72]. The weight of evidence suggested supplements are 
unlikely to be effective at improving arthralgia (Table 4). 
The majority of primary data referred to within the reviews 
and guidelines were from weak study designs and small sam-
ple sizes. Observational designs tended to yield larger effects 
in favour of supplement use.
Relaxation
One lower quality clinical guideline reported evidence from 
a systematic review and meta-analysis suggesting a moderate 
to large effect of relaxation techniques on arthralgia [75]. 
However, no details were provided on techniques or quality 
of the evidence.
Miscellaneous
One low-quality systematic review identified a single trial of 
whole body vibration, which indicated no effect on a range 
of arthralgia outcomes [39].
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Fatigue
Eight systematic reviews [28, 36, 39, 43, 44, 55, 57, 58] 
and nine clinical guidelines [61, 63, 66, 68, 69, 72, 73, 76, 
77] referred to self-management strategies for fatigue. Three 
systematic reviews were rated as high quality [55, 57, 58]. 
Three clinical guidelines scored > 50% with regard to qual-
ity [61, 63, 68].
Acupuncture
Three systematic reviews [36, 39, 44], two higher quality 
clinical guidelines [63, 68], and one lower quality clini-
cal guideline [77] reported on the use of acupuncture to 
support fatigue. There were no high-quality reviews. In a 
moderate quality systematic review and meta-analysis of 
four studies, acupuncture was reported to be ineffective at 
managing fatigue in women with breast cancer [44]. One 
guideline graded acupuncture as ‘C’ whereby ‘clinicians are 
advised to selectively recommend offering acupuncture to 
patients based on professional judgement and patient prefer-
ence [63].’ A second guideline reported evidence from two 
randomised trials of acupuncture, indicating it may relieve 
fatigue, but without an evidence grading [68]. A lower qual-
ity guideline reported evidence supporting the use of acu-
puncture for fatigue, but the guideline panel could not reach 
a consensus in its recommendation [77].
Supplements
Three systematic reviews [30, 39, 42] and two clinical guide-
lines [63, 77] reviewed at least one supplement as a strat-
egy for managing fatigue. A moderate quality systematic 
review [43] and a critically low-quality systematic review 
[30] investigated the use of black cohosh to address cancer-
related fatigue. The moderate quality review identified a sin-
gle observational study, which demonstrated no association 
between the supplement and fatigue [43]. The low-quality 
systematic review identified a single randomised controlled 
trial at high risk of bias, testing Chinese herbs for fatigue 
[36]. While changes to fatigue were observed in the inter-
vention group, the review concluded this effect should be 
interpreted with caution. A low-quality systematic review 
reported data from a single trial indicating spore powder 
of G. Lucidum improved fatigue in this population [39]. A 
clinical guideline graded the evidence for Ginseng as ‘Grade 
C’ indicating equivocal evidence. The same guideline also 
discouraged the use of Acetyl-L-carntine and Guarana due 
to moderate or high certainty that there is no net benefit 
(Grade D) [63]. A lower quality guideline did not recom-
mend guarana or mistletoe extract for fatigue [77].
Physical activity
Seven systematic reviews [28, 36, 39, 52, 55, 57, 58] and 
nine clinical guidelines [61, 63, 66, 68, 69, 72, 73, 76, 77] 
included physical activity interventions for fatigue. One 
high-quality systematic review investigated the effect of 
Tai Chi exercise on physical wellbeing, mostly measured 
using the Chronic Illness Therapy – Fatigue survey [55]. 
In their meta-analysis of five trials, no overall beneficial 
effect was observed. This finding is supported by a sec-
ond high-quality systematic review [58]. A third high-
quality review concluded yoga could reduce fatigue in 
the short term but not medium-term compared with no 
therapy [57]. It also reported there was very low-quality 
evidence to suggest yoga is comparable to other physical 
activity interventions. A low-quality review found no evi-
dence for effects of other low intensity physical activity 
interventions, such as massage therapy [36]. Four clinical 
guidelines recommended yoga [63, 68, 69, 77] (AGREE-2 
range = 40–56%).
A high-quality review demonstrated that aerobic exer-
cise was consistently beneficial for fatigue, but there was 
weak and inconclusive effects for resistance training 
[58]. One lower quality clinical guideline recommended 
combining aerobic and resistance exercise (category 1. 
High-level evidence and consensus that it was appro-
priate) [69]. Five guidelines recommended unspecified 
physical activity [61, 66, 68, 69, 72, 73, 76] (AGREE-2 
range = 32–71%), although three provided no evidence for 
this recommendation [72, 73, 76]. In two mixed quality 
clinical guidelines, the evidence provided was graded as 
level I (recommendation based on meta-analysis) [61] and 
level II (recommendation based on non-randomised trials 
or observational data) [66].
Behavioural strategies
Three lower quality clinical guidelines recommended a 
range of strategies, including avoiding long periods in bed 
[72], consuming enough fruit, vegetables and water [72], 
and rest [66, 76]. None were supported by peer-reviewed 
evidence.
Hypnosis
One clinical guideline included hypnosis as a strategy for 
managing fatigue [63] (AGREE-2 score = 52%). Its grad-
ing (grade C) indicated clinicians should selectively offer 
hypnosis to patients. No systematic reviews were identified 
for hypnosis and fatigue management.
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Miscellaneous
A low-quality systematic review reported a single study of 
neuromuscular taping which demonstrated s lower fatigue 
in the intervention group compared with a control group 
at 5-weeks post-intervention [39]. The same review also 
reported data from a single trial reporting no effect of whole 
body vibration on fatigue.
Hot flashes
Hot flashes were the most common symptom covered by 
systematic reviews (n = 13) [29, 32, 34, 35, 37, 42–46, 53, 
54, 56] and clinical guidelines (n = 9) [60–63, 65, 71, 72, 
74, 75]. Three systematic reviews were rated as high quality 
[53, 54, 56]. Four clinical guidelines were higher quality 
[61, 63, 71, 74].
Acupuncture
Eight systematic reviews [32, 34, 35, 44–46, 53, 56] and 
four clinical guidelines [62, 63, 71, 72] reported on the use 
of acupuncture for managing hot flashes. Three systematic 
reviews were rated as low quality [32, 34, 35], three as mod-
erate quality [44–46] and two as high quality [53, 56]. The 
quality of the guidelines ranged from 32 to 58%. The high-
quality reviews concluded there was either no evidence for 
acupuncture for this indication [56] or there was no effect 
of acupuncture when compared with active pharmacological 
interventions [53]. Within-group analysis and a lack of long-
term follow-up were consistent limitations within trials. The 
clinical guidelines indicated mixed evidence for acupuncture 
for managing hot flashes [62, 63, 71, 72] (Table 4).
Supplements
Nine systematic reviews [29, 30, 39, 42, 43, 51, 53, 54, 56] 
and five clinical guidelines [60, 62, 63, 71, 75] reported 
10 different supplements for the self-management of hot 
flashes. Supplements included vitamin E [29, 53, 56, 60, 
62], soy [29, 42, 62, 63, 75], black cohosh [29, 30, 43, 62, 
71], Omega 3 [71], Flaxseed [62], magnesium oxide [62], 
homeopathy [39, 54, 56, 71], herbal medicine [51], medici-
nal plant extract (guarana) [39], and St John’s wort [30, 75]. 
The overall weight of evidence within the systematic reviews 
indicated no effect of supplements on hot flashes, with wide-
spread study weaknesses within the field (Table 4).
Hypnosis
Hypnosis was investigated as a strategy to support hot flashes 
in two systematic reviews [37, 53], and was also included 
in three clinical guidelines [65, 71, 72]. A high-quality 
systematic review identified only one relevant trial that was 
stopped prematurely due to recruitment difficulties [53]. 
One higher quality clinical guideline reported the body of 
evidence was weak and cautiously suggested hypnotherapy 
could be considered (grade D) [71], and a second lower 
quality guideline cited the same clinical trial suggesting 
hypnosis could be a promising strategy for managing hot 
flashes. They graded the evidence as ‘Level 1’ (i.e. based on 
high-quality trials or systematic reviews) [65].
Relaxation
Two systematic reviews [35, 56] and two clinical guidelines 
[62, 71] included relaxation as a strategy for self-managing 
hot flashes. The systematic reviews were rated as high [56] 
and low [35] quality. The clinical guidelines scored 32% [62] 
and 58% [71] using the AGREE-2 checklist. Both reviews 
included two relevant studies, reporting mixed evidence for 
effects on hot flashes. There was a tendency to report within-
group rather than between-group differences within the indi-
vidual trials. One guideline reported absent effects in trials 
with adequate control arms [62], while the other indicated 
limited evidence of reductions in hot flash frequency and 
severity [71].
Behavioural strategies
Four clinical guideline recommended a range of strategies, 
including lifestyle and environment modifications [61, 62, 
74, 75]. Suggestions included avoiding caffeine, alcohol and 
spicy foods, sipping cool drinks, reducing stress, changing 
to a cool room temperature, use of portable fans, open-
ing windows, weight loss, wearing loose cotton clothing, 
and dressing in layers. No evidence was provided for these 
recommendations.
Physical activity
A moderate quality systematic review concluded Tai Chi 
was ineffective for hot flashes [52]. Three clinical guidelines 
reported on physical activity for hot flashes, all focusing on 
yoga [65, 71, 72] (AGREE-2 range = 32–58%). One guide-
line indicated no effect of yoga on vasomotor symptoms 
[65], while a second recommended it without referring to 
peer-reviewed evidence [72]. The final guideline reported 
two individual trials among women with breast cancer indi-
cating yoga may reduce the frequency and severity of hot 
flushes and, when combined with meditation, also improve 
overall menopausal symptoms [71]. Both trials were 
assessed by the guideline developers as having a moderate 
risk of bias.
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Magnetic therapy
No systematic reviews and two clinical guidelines reported 
on the use of magnetic therapy for the treatment of hot 
flashes [71, 75] (AGREE-2 scores = 58% and 33%). One 
clinical guideline reported a single randomised controlled 
trial indicating no effect of magnetic therapy, with the 
placebo arm reporting a lower frequency of hot flashes at 
follow-up. This was graded as a ‘C’ quality of evidence, 
indicating cautious application of the recommendation. The 
second clinical guideline concluded magnetic devices are 
not advised for this population.
Weight loss
No systematic reviews were identified reporting on the role 
of weight loss and hot flashes, and one clinical guideline did 
report on this [65] (AGREE-2 score = 49%). The authors 
cited a secondary analysis of a randomised dietary trial, 
indicating women with breast cancer who had lost at least 
10% of their bodyweight during the 2-year follow-up were 
less likely to report moderate or severe vasomotor symp-
toms. The guideline indicated the evidence for weight loss 
on vasomotor symptoms (not distinguishing breast cancer 
and general population samples) was level II, indicating it 
may be beneficial for alleviating vasomotor symptoms.
Vulvovaginal symptoms
Three low-quality systematic reviews were identified for vul-
vovaginal symptoms [37–39], and self-management strate-
gies to address these symptoms were included in nine clini-
cal guidelines [61, 67, 70–76]. Four guidelines scored > 50% 
with regard to quality [61, 67, 71, 74].
Moisturisers, gels, and lubricants
A low-quality systematic review [38] and nine clinical guide-
lines of mixed quality [61, 67, 70–76] all supported the use 
of moisturisers, gels or lubricants for this indication. Three 
guidelines did not refer to peer-reviewed literature [72–74]. 
The systematic review reported reductions in vaginal dry-
ness and dyspareunia when using a pH-balanced gel and 
a vaginal moisturiser [38], and reduced dyspareunia when 
using aqueous lidocaine. A higher quality clinical guideline 
recommended the use of lubricants for all sexual touch in 
addition to frequent application of vaginal moisturiser [67]. 
A second higher quality clinical guideline reported a 1A 
level of evidence (based on RCTs) for non-hormonal water-
based lubricants and moisturisers for vaginal dryness [61].
Vaginal dilators
Three clinical guidelines recommended the use of dilators to 
address vaginismus and vaginal stenosis [67, 70, 76]. It was 
not clear whether these recommendations were informed by 
primary research undertaken with women affected by breast 
cancer.
Physical activity
A systematic review rated as low quality [37] and a higher 
quality clinical guideline [67] reported on the evidence 
for physical activity and vulvovaginal symptoms. The sys-
tematic review reported two randomised trials of exercise 
interventions that had no effect on sexual functioning. The 
clinical guideline focussed on general exercise and pelvic 
floor exercises and reported these may be effective to sup-
port vulvovaginal discomfort and lower urinary tract symp-
toms. It was unclear what primary research informed this 
recommendation.
Supplements
A low-quality systematic review reported there was no effect 
of medicinal plant extract (guarana) on sexual function [39].
Sleep disturbance
Six systematic reviews of varying quality [30, 39, 44, 51, 
52, 57] and five clinical guidelines [63, 71–74] reported on 
strategies to address sleep disturbance in women with breast 
cancer. Three guidelines scored > 50% with regard to quality 
[63, 71, 74].
Physical activity
A high-quality systematic review identified eight 
relevant studies comparing yoga to no therapy (n = 6) 
or psychological interventions (n = 2) [57]. It concluded 
yoga is favourable in comparison with no therapy, but 
not psychological interventions for sleep disturbance. A 
moderate-quality systematic review also indicated there was 
no long-term effect of Tai Chi on sleep [52]. A low-quality 
systematic review reported physical activity interventions 
may improve several sleep-related outcomes, although the 
interventions were poorly defined [39]. A clinical guideline 
reported there was equivocal evidence or small net benefit 
(grade C) for gentle yoga in improving sleep quality [63] 
(AGREE-2 score = 52%).
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Acupuncture
A moderate quality systematic review reported a single 
acupuncture trial demonstrating this intervention did not 
significantly improve sleep quality [44]. Two clinical 
guidelines included acupuncture for sleep disturbance [71, 
72], although only one referred to peer-reviewed evidence 
[71]. This guideline cited a single randomised trial, which 
indicated acupuncture improved sleep quality compared 
with sham acupuncture, but only within group differences 
were reported.
Hypnosis
Two clinical guidelines included hypnosis for sleep dis-
turbance, although only one referred to peer-reviewed 
evidence [71, 72]. This reported a single randomised 
trial with a moderate risk of bias indicating hypnotherapy 
improved sleep quality when compared with a no treat-
ment control [71].
Supplements
A low-quality systematic review reported herbal medicine 
may alleviate insomnia [51]. A systematic review rated as 
critically low quality reported black cohosh (with or with-
out St John’s wort) may be effective at improving sleep 
disturbance. A higher quality clinical guideline reported 
a single randomised trial comparing gabapentin with vita-
min E over 12 weeks [71]. Their findings indicated vita-
min E had no effect on sleep disturbance compared with 
gabapentin.
Behavioural strategies
Three clinical guidelines recommended a range of behav-
ioural strategies to improve sleep quality, although none 
were supported by peer-reviewed evidence [72–74]. These 
included sleep hygiene techniques, such as not exercising 
late in the day, maintaining a regular bedtime, avoiding 
stimulants (e.g. caffeine, alcohol), restricting the bedroom 
for sleep, avoiding napping, and keeping the bedroom 
cool.
Miscellaneous
A low-quality systematic review reported neuromuscular 
taping did not reduce sleep disturbance [39].
Gastrointestinal discomfort
One high-quality systematic review and meta-analysis 
reported on the use of acupuncture to manage gastro-
intestinal discomfort [44]. No clinical guidelines were 
identified.
Acupuncture
Five studies were included in the meta-analysis, which 
showed no benefit of acupuncture on gastrointestinal dis-
comfort [44].
Nausea
One clinical guideline reported on the topic of nausea 
induced by AET [74] (AGREE-2 score = 52%). No system-
atic reviews were identified.
Behavioural strategies
The NICE clinical guideline recommended that women 
should take tamoxifen with food or milk, or at night [74]. 
No empirical evidence was provided.
Discussion
In this umbrella review of clinical guidelines and systematic 
reviews, there was no clear evidence to support the majority 
of self-management strategies currently recommended and 
used by breast cancer survivors experiencing side-effects 
from AET. Unanimous agreement was only observed for 
moisturisers, lubricants and gels for women affected by 
vulvovaginal symptoms, where a systematic review and 
seven clinical guidelines endorsed this strategy. Consider-
ing the prevalence of side-effects of AET [2–6], and that 
over a quarter of women with these symptoms attempt self-
management, there should be a renewed focus in evaluat-
ing and implementing support for breast cancer survivors 
[6]. Healthcare professionals supporting the management 
of breast cancer survivors should counsel women that the 
evidence supporting most self-management strategies for 
AET side-effects have a weak and inconsistent evidence 
base. While many strategies are low risk, patients should be 
encouraged to seek healthcare professional support if they 
do not alleviate their symptoms, as evidence supporting 
pharmacological interventions appears stronger [78].
Despite the wide-ranging benefits of physical activity 
observed among cancer populations [79–81], and its inclu-
sion in multiple clinical guidelines identified here [61, 63, 
65, 66, 68, 69, 71–73, 76, 77], there was often weak or 
inconclusive evidence from systematic reviews to support 
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this strategy for arthralgia, fatigue, hot flashes, vulvovagi-
nal symptoms and sleep disturbance in women affected by 
breast cancer using AET. This was particularly the case for 
low intensity activities such as Tai Chi and yoga. Among 
the high-quality systematic reviews, yoga [57] and aerobic 
exercise [58] was shown to be effective for fatigue, although 
yoga may only be beneficial in the short-term. The conclu-
sion that the evidence for physical activity for self-managing 
AET symptoms is weak or inconclusive was made on the 
basis that the majority of the primary research informing 
these reviews was affected by either low statistical power, 
poor study design or inadequate follow-up. A rare example is 
a trial led by Irwin and colleagues [82] which strongly influ-
enced the evidence to support physical activity for arthral-
gia within the reviews and guidelines. Such trials suggest it 
would be premature to conclude that physical activity is inef-
fective for self-managing AET, but similar high-quality stud-
ies are needed. Specifically, further information is needed to 
inform precise recommendations for physical activity type, 
duration and intensity of physical activity. Reporting guide-
lines such as the Consensus on Exercise Reporting Tem-
plate (CERT) could be also more widely used to improve 
the specificity of reporting [83].
We aimed to observe the extent to which guidelines ade-
quately reflected scientific evidence generated in systematic 
reviews. Strategies with at least some supporting evidence 
for a beneficial effect were generally appropriately reflected 
in the clinical guidelines, as indicated by moisturisers, gels 
and lubricants, and physical activity. However, there were 
examples of clinical guidelines introducing recommended 
strategies not supported by systematic review evidence. For 
example, weight loss and physical activity for hot flashes, 
hypnosis for fatigue and sleep, and behavioural strategies 
for fatigue, hot flashes, and sleep. In the case of dilators 
for vulvovaginal symptoms, the clinical guidelines largely 
relied on narrative reviews and early phase pilot trials, and 
our search did not identify any systematic reviews in this 
area. A systematic review of dilators for this indication could 
therefore be warranted.
The reviews and guidelines identified observed consistent 
weaknesses with the primary research they included, which 
often led us to conclude that the evidence for strategies was 
inconclusive. The use of acupuncture for arthralgia is a useful 
example to illustrate this point. Weak study designs were 
common, including observational studies with a high risk of 
bias and underpowered pilot trials that relied upon within-
group rather than between-group comparisons. Short-term 
follow-up within clinical trials was also widespread, which 
can limit the extent to which these data apply to women using 
AET over a 5- to 10-year period [84]. These weaknesses 
were common, but not ubiquitous, and the mixed evidence 
may explain why others have concluded this strategy to be 
efficacious for this indication [78]. Adequately powered trials 
of promising supportive care interventions with long-term 
follow-up are needed to inform clinical guidelines.
There were also weaknesses with regard to the reviews 
that we identified. Overall, 13 (39%) systematic reviews 
were rated as either low or critically low quality. Our finding 
that duplicate data extraction was only present in less than 
half of the reviews is particularly problematic. There was a 
high degree of overlap with regard to the strategies assessed 
for specific indications within the systematic reviews. For 
example, we identified 11 systematic reviews reporting 
on the use of acupuncture for arthralgia. This is a form of 
research waste, as evidenced by so few clinical guidelines 
including acupuncture for arthralgia management. This 
duplication could be addressed through pre-registration of 
systematic review protocols.
The quality of some clinical guidelines was also low, and 
they often made recommendations without citing evidence 
or reporting evidence for strategies that had only been tested 
in healthy populations or different clinical groups. Most 
guidelines failed to consider potential barriers to imple-
mentation within routine clinical care. Guideline develop-
ers should consider describing the resource implications 
of applying recommendations and suggest audit criteria to 
monitor and drive implementation. Furthermore, editorial 
independence was assessed as being particularly poor for 
the guidelines identified. To improve transparency within 
guideline development, the views of the funding body and 
competing interests of the contributors should be disclosed 
and easy to identify.
Our decision to include both systematic reviews and clini-
cal guidelines enabled us to produce a more comprehensive 
review with a broader range of self-management strategies. 
However, a limitation that should be acknowledged is that 
synthesizing the data from each document type simultane-
ously was often challenging because the purpose of each 
document is inherently different. For example, the clinical 
guidelines endorsing physical activity were likely to con-
sider the wide-ranging benefits observed among cancer 
populations [79–81], and therefore their recommendations 
may not have been based solely on the evidence for self-
managing symptoms of AET. This wider context should be 
considered when comparing guidelines with the findings 
of systematic reviews. Our ability to compare each docu-
ment type was further limited by the differences between 
the quality assessment tool we used for each, making the 
quality scores difficult to compare. We included all reviews 
and guidelines regardless of the quality scores they were 
given. While we gave greater weight to the higher quality 
reviews and guidelines within our narrative synthesis, dif-
ferent conclusions may have been drawn had we excluded 
publications considered to be lower quality.
Further limitations are that we excluded pharmacological 
approaches and strategies that would require healthcare 
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professional supervision, many of which have known efficacy 
[78]. Patients should be encouraged to seek healthcare 
professional support if the initial self-management strategies 
are ineffective. For pragmatic reasons we did not search all 
databases for the clinical guidelines, and this may also have 
led us to miss important documents. Side-effects such as 
nausea and fatigue are associated with a range of breast 
cancer treatments, but our review focussed on literature 
involving women using AET. Effective self-management 
interventions tested among women experiencing these 
symptoms who are not using AET could also be useful, but 
may require evaluation before being widely recommended. 
Finally, a limitation of the umbrella review method overall 
is that too much weight is placed on primary studies that are 
cited across multiple reviews and guidelines. This should be 
considered when interpreting our findings.
In conclusion, we identified a large body of systematic 
reviews and clinical guidelines of self-management strate-
gies for women experiencing side-effects from AET. How-
ever, unanimous agreement for a strategy was only observed 
for moisturisers, gels and lubricants for women experiencing 
vulvovaginal symptoms. Evidence supporting physical activ-
ity for AET symptoms was only clear for aerobic activity and 
yoga for alleviating fatigue. Breast cancer survivors should 
therefore be cautious about using most self-management 
strategies currently recommended for AET side-effects. 
Healthcare professionals should be aware that although the 
risk of harm is unlikely with most of these strategies, the 
likelihood of benefit is often unclear. Primary research in 
this area relied heavily on inadequately powered trials using 
poor study designs. A large proportion of the systematic 
reviews and clinical guidelines identified were also of lower 
quality. There is a need for high-quality longitudinal pri-
mary research of promising self-management interventions 
for women with breast cancer using AET. Findings from 
such trials should be incorporated within clinical guidelines 
that have considered how to implement these strategies into 
routine practice.
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